Literature DB >> 15666862

Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine-phosphodiester-guanine motifs.

Susantha Gomis1, Lorne Babiuk, Brenda Allan, Philip Willson, Edwin Waters, Neil Ambrose, Rolf Hecker, Andrew Potter.   

Abstract

Oligodeoxynucleotides (ODN) containing cytosine-phosphodiester-guanine (CpG) motifs have been shown to be effective immunoprotective agents in murine models for a variety of viral, intracellular bacterial, and protozoan infections. We recently have shown that CpG ODN protects against extracellular bacterial infections in mature chickens. The objective of this study was to investigate the effect of CpG ODN on Escherichia coli septicemia in neonatal broiler chicks. Two-day-old chicks, or embryonated eggs that had been incubated for 18 or 19 days, received 50 microg CpG ODN. Three days after exposure to CpG ODN, a virulent isolate of E. coli was inoculated subcutaneously in the neck of each bird. Birds were examined for 7 days post-E. coli challenge and dinical, pathologic, and bacteriologic assessments were conducted. The control group of birds that received no CpG ODN had a survival rate of 0% to 20%. In contrast, groups that received CpG ODN, either by intramuscular or in ovo routes, had significantly higher survival rates (P < 0.0001). Bacterial counts in air sacs were significantly lower when birds or embryos were treated with CpG ODN as compared with controls. A dose as low as 10 microg of CpG ODN, administered intramuscularly, was able to protect birds significantly against E. coli challenge. Formulation of CpG ODN with 30% Emulsigen did not enhance the protection. This study demonstrates that CpG ODN has systemic protective effects in broiler chicks against E. coli infections. This is the first time that CpG ODN has been demonstrated to have an immunoprotective effect against a bacterial infection in chicks following in ovo delivery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15666862     DOI: 10.1637/7194-041204R

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  17 in total

Review 1.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

2.  Expression analysis of turkey (Meleagris gallopavo) toll-like receptors and molecular characterization of avian specific TLR15.

Authors:  Kannaki T Ramasamy; Maddula R Reddy; Prem C Verma; Shanmugam Murugesan
Journal:  Mol Biol Rep       Date:  2012-06-15       Impact factor: 2.316

3.  Characterization of Dosage Levels for In Ovo Administration of Innate Immune Stimulants for Prevention of Yolk Sac Infection in Chicks.

Authors:  Mishal Sarfraz; Thuy Thi Thu Nguyen; Colette Wheler; Wolfgang Köster; Volker Gerdts; Arshud Dar
Journal:  Vet Sci       Date:  2022-04-22

Review 4.  Antiinfective applications of toll-like receptor 9 agonists.

Authors:  Arthur M Krieg
Journal:  Proc Am Thorac Soc       Date:  2007-07

5.  Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys.

Authors:  Jean-Rémy Sadeyen; Zhiguang Wu; Holly Davies; Pauline M van Diemen; Anita Milicic; Roberto M La Ragione; Pete Kaiser; Mark P Stevens; Francis Dziva
Journal:  Vet Res       Date:  2015-01-23       Impact factor: 3.683

6.  In ovo delivery of CpG DNA reduces avian infectious laryngotracheitis virus induced mortality and morbidity.

Authors:  Simrika Thapa; Mohamed Sarjoon Abdul Cader; Kalamathy Murugananthan; Eva Nagy; Shayan Sharif; Markus Czub; Mohamed Faizal Abdul-Careem
Journal:  Viruses       Date:  2015-04-08       Impact factor: 5.048

7.  Potential mediators of in ovo delivered double stranded (ds) RNA-induced innate response against low pathogenic avian influenza virus infection.

Authors:  Hanaa Ahmed-Hassan; Mohamed Sarjoon Abdul-Cader; Upasama De Silva Senapathi; Maha Ahmed Sabry; Eman Hamza; Eva Nagy; Shayan Sharif; Mohamed Faizal Abdul-Careem
Journal:  Virol J       Date:  2018-03-12       Impact factor: 4.099

8.  In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection.

Authors:  Mohamed Sarjoon Abdul-Cader; Aruna Amarasinghe; Victor Palomino-Tapia; Hanaa Ahmed-Hassan; Khawaja Bakhtawar; Eva Nagy; Shayan Sharif; Susantha Gomis; Mohamed Faizal Abdul-Careem
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

9.  In Ovo Administration of CpG ODN Induces Expression of Immune Response Genes in Neonatal Chicken Spleen.

Authors:  Joanna Sajewicz-Krukowska; Monika Olszewska-Tomczyk; Katarzyna Domańska-Blicharz
Journal:  J Vet Res       Date:  2017-12-27       Impact factor: 1.744

10.  Protective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coli.

Authors:  Tryntsje Cuperus; Albert van Dijk; Mieke G R Matthijs; Edwin J A Veldhuizen; Henk P Haagsman
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.